Abstract:Abstract The randomized play-the winner (RPW) rule is very useful in clinical trials for patient allocation with two treatments. Wei (1979) introduces the generalized Friedman’s urn (GFU) model to clinical trials of K treatment (as an extension of the RPW). In this paper, we consider a general kind of adaptive designs, whose generations depend on an estimated parameter, for example the estimated success rate. Using this kind of adaptive designs, more informations of previous stages are used to update the model at each stage, and more patients may be assigned to a better treatment than the RPW rule and Wei’s rule. The strong consistency and the asymptotic normalities are established for both the urn composition and the number of patients assigned to each treatment. A adaptive design proposed by Bai, Hu and Shen (2001) recently is a simple special example. 1 Introduction and main results 1.1 Introduction and the Model In comparing of K treatments, suppose that patients are available for the study sequentially and must be assigned to a treatment group immediately upon arrival. Adaptive designs, which use accumulating information to assign patients to treatments, tend to assign more patients to better treatments in clinical trials. A typical probability model for adaptive clinical trials is the Generalized Friedman’s Urn (GFU) model (also named as Generalized P´olya Urn (GPU) in literature). The model is described as follows. Consider an urn containing particles of K types, respectively representing K ’treatments’ in a clinical trial. The patients are to be allocated sequentially to the treatments. At the beginning, the urn contains Y0 = (Y0;1;:::;Y0;K) particles, where Y0;k > 0 denotes the number of particles of type k, k = 1;:::;K. At stage i, i = 1;2;:::, a particle is drawn from the urn and replaced. If the particle is of type k, then the treatment k is assigned to the i-th patient, k = 1;:::;K, i = 1;2;:::. After observing a random variables »i;k which may be considered as the response of the i-th patient on the treatment k, an additional Di(k;q;»i;k) particles of type q,

New results on optimal conditional error functions for adaptive two-stage designs

Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints

Conditional Power and Friends: The Why and How of (Un)planned, Unblinded Sample Size Recalculations in Confirmatory Trials

On the Relative Efficiency of Model-Assisted Designs: a Conditional Approach.

Central Limit Theorems of a Recursive Stochastic Algorithm with Applications to Adaptive Designs

Statistical Inference of Adaptive Randomized Clinical Trials for Personalized Medicine

Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive design

Changing interim monitoring in response to internal clinical trial data

Selective Randomization Inference for Adaptive Experiments

An Adaptive Trial Design to Optimize Dose-Schedule Regimes with Delayed Outcomes

The advantages and disadvantages of adaptive designs for clinical trials

Covariate-adjusted response-adaptive designs for generalized linear models

ASYMPTOTIC PROPERTIES OF ADAPTIVE DESIGNS VIA STRONG APPROXIMATIONS

The asymptotic theorems of adaptive designs for clinical trials with generations depending on the estimated success rates

Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors

Optimising the Trade-Off Between Type I and Type II Errors: A Review and Extensions

On Estimating the Selected Treatment Mean under a Two-Stage Adaptive Design

Point estimation for adaptive trial designs I: a methodological review

Asymptotic Results on a Class of Adaptive Multi-Treatment Designs

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table

Response adaptive randomization procedures in seamless phase II/III clinical trials.